Proteomic Profiling of Cerebrospinal Fluid and Serum in Schizophrenia Using a Label-free Mass Spectrometric Approach

Library Number:
720002305EN
Part Number:
720002305EN
Author(s):
Michael R. Morris, Thérèse McKenna, Hilary Major, Emanuel Schwarz , Markus Leweke, Jeffrey T.J. Huang, Sabine Bahn, and James Langridge
Source:
AACC 2007, July 15 - 19, San Diego, Ca
Content Type:
Posters
Content Subtype:
AACC
Related Products:
Endocrinology
 
masstrak_amino_acid_analysis_for_consumables
In this study, we employed a label-free mass spectrometry based approach to determine proteomic profiles from CSF and sera samples from first-onset, drug-naïve paranoid schizophrenia patients and healthy controls. Seventy seven proteins were detected with high confidence, in at least three of the samples. Of these, seven proteins were newly identified in CSF. Partial least squares discriminant analysis showed a significant separation of first-onset, drug-naive schizophrenia    patients away from healthy controls in this study. From this study a number of putative biomarker proteins, some associated with other neurological disorders are undergoing further validation.

Title Format File Size
720002305en PDF 1722.74kB